(Q36284079)

13 August 2017

title

Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs (English)

1 reference

13 August 2017

0 references

Grant H Skrepnek

1

1 reference

13 August 2017

Jacob Abarca

2

1 reference

13 August 2017

Daniel C Malone

3

1 reference

13 August 2017

Edward P Armstrong

4

1 reference

13 August 2017

Farshad M Shirazi

5

1 reference

13 August 2017

Raymond L Woosley

6

1 reference

13 August 2017

language of work or name

English

0 references

publication date

11 October 2005

1 reference

Annals of Pharmacotherapy

13 August 2017

published in

1 reference

13 August 2017

volume

39

1 reference

13 August 2017

issue

11

1 reference

13 August 2017

page(s)

1785-1791

1 reference

The epidemiology of heart failure: the Framingham Study

13 August 2017

cites work

1 reference

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

21 January 2018

1 reference

New therapeutic options in congestive heart failure: Part II.

21 January 2018

1 reference

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

21 January 2018

1 reference

Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge

21 January 2018

1 reference

National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction

21 January 2018

1 reference

Race, quality of care, and outcomes of elderly patients hospitalized with heart failure

21 January 2018

1 reference

Angiotensin-converting enzyme inhibitor therapy in patients with heart failure enrolled in a managed care organization: effect on costs and probability of hospitalization

21 January 2018

1 reference

Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopri

21 January 2018

1 reference

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective

21 January 2018

1 reference

Congestive heart failure in the United States: is there more than meets the I(CD code)? The Corpus Christi Heart Project.

21 January 2018

1 reference

On estimating efficacy from clinical trials

21 January 2018

1 reference

The use of claims databases for outcomes research: rationale, challenges, and strategies

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1G124

1 reference

13 August 2017

1 reference